Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Curis Inc (CRIS)

Curis Inc (CRIS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Curis Inc 128 SPRING STREET BUILDING C SUITE 500 LEXINGTON MA 02421 USA

P: 617-503-6500

Description:

Curis, Inc. is a therapeutic drug development company focusing on cancer, neurological and dermatological disease indications, with technologies that utilize regulatory pathways that control repair and regeneration. Curis' product development involves the use of small molecules or proteins to modulate these pathways. The company has successfully used this technology and product development approach to produce several promising drug product candidates in the fields of cancer, neurological disorders, hair growth, kidney and other diseases, as well as cardiovascular disease.

Key Statistics

Overview:

Market Capitalization, $K 772,154
Shares Outstanding, K 91,596
Annual Sales, $ 10,840 K
Annual Net Income, $ -29,910 K
Last Quarter Sales, $ 2,290 K
Last Quarter Net Income, $ -10,840 K
60-Month Beta 2.90
% of Insider Shareholders 4.84%
% of Institutional Shareholders 88.55%
Float, K 87,163
% Float 95.16%

Growth:

1-Year Return 642.06%
3-Year Return 329.19%
5-Year Return -52.88%
5-Year Revenue Growth 37.56%
5-Year Earnings Growth 56.43%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year 29.41%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 05/30/18

CRIS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.61
Price/Earnings to Growth N/A
Return-on-Equity % -40.73%
Return-on-Assets % -22.03%
Profit Margin % -275.92
Net Margin % -486.84
Debt/Equity 0.00
Price/Sales 67.63
Price/Cash Flow N/A
Price/Book 6.91
Book Value/Share 1.23
Interest Coverage -4.86
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar